Skip to content

MaxCyte MXCT Operating margin

Operating margin at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
8.8%-3.1pp
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
17.2%+0.8pp
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-210.7%+7.6pp
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
-144.2%-12.7pp
PDE
Pro-Dex, Inc.PDEX
14.5%-3.8pp
Repligen logo
RepligenRGEN
1.5%-14.0pp

Other financials

Income statement

See full
Revenue$9.7M-7.1%
Gross profit$8.1M-9.1%
Operating income-$6.2M+49.7%
Net income-$4.8M+53.7%
EPS (diluted)-$0.04+60.0%

Balance sheet

See full
Cash & equivalents$14.6M-37.8%
Total debt$17.5M-7.1%
Total equity$167.9M-15.8%
Total assets$194.5M-15.4%

Cash flow

See full
Operating cash flow-$8.2M+43.3%
CapEx$72.0K-89.0%
Free cash flow-$8.2M+45.3%

Valuation

See full
Market cap$130.15M-46.8%
Enterprise value$133.08M-46.3%
P/S-2.8×

Profitability

See full
Gross margin80.5%-0.4pp
Net margin-121.2%+12.3pp
FCF margin-90.9%+3.7pp

Returns & leverage

See full
Return on equity-21.3%+2.0pp
Debt / equity0.1×0.0×
Current ratio12×-0.2×

Where this comes from

Calculated from MaxCyte’s reported figures.

Based on trailing twelve months.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MaxCyte's operating margin?
MaxCyte (MXCT) reported operating margin of -141.8% in Q1 2026.
How has MaxCyte's operating margin changed year-over-year?
MaxCyte's operating margin decreased by 4.3% year-over-year, from -135.9% to -141.8%.
What is the long-term trend for MaxCyte's operating margin?
Over 5 years (2020 to 2025), MaxCyte's operating margin has grown at a 30.0% compound annual growth rate (CAGR), from -42.3% to -157.1%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.